We are live on ! Find out more
BIM

Bridges Investment Management Portfolio holdings

AUM $8.22B
1-Year Est. Return 21.38%
This Fund
S&P 500
This Quarter Est. Return
+13.18%
1 Year Est. Return
+21.38%
3 Year Est. Return
+77.85%
5 Year Est. Return
+98.89%
10 Year Est. Return
+374.69%
AUM
$2.45B
AUM Growth
+$323M
Cap. Flow
+$55.7M
Cap. Flow %
2.27%
Top 10 Hldgs %
32.87%
Holding
353
New
9
Increased
138
Reduced
125
Closed
12

Top Sells

Rank Stock Value
1
ETN icon
Eaton
ETN
+$6.49M
2
CELG
Celgene Corp
CELG
+$6.15M
3
GILD icon
Gilead Sciences
GILD
+$5.79M
4
SYF icon
Synchrony
SYF
+$5.42M
5
STZ icon
Constellation Brands
STZ
+$5.39M

Sector Composition

Rank Sector Weight
1 Financials 21.71%
2 Technology 11.28%
3 Industrials 10.08%
4 Healthcare 9.16%
5 Consumer Discretionary 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
151
Kimberly-Clark
KMB
$35.9B
$1.46M 0.06%
11,813
+456
+4% +$53K
CNK icon
152
Cinemark Holdings
CNK
$4.38B
$1.45M 0.06%
36,320
+7,000
+24% +$274K
ICE icon
153
Intercontinental Exchange
ICE
$84.5B
$1.45M 0.06%
19,024
-8,200
-30% -$614K
GGG icon
154
Graco
GGG
$13.5B
$1.42M 0.06%
28,720
+5,350
+23% +$242K
TD icon
155
Toronto Dominion Bank
TD
$200B
$1.42M 0.06%
26,100
-1,500
-5% -$82.9K
AZTA icon
156
Azenta
AZTA
$1.54B
$1.42M 0.06%
48,290
+8,800
+22% +$265K
BOH icon
157
Bank of Hawaii
BOH
$3.1B
$1.42M 0.06%
17,950
+3,290
+22% +$258K
HF
158
DELISTED
HFF Inc.
HF
$1.4M 0.06%
29,360
+6,200
+27% +$263K
TROW icon
159
T. Rowe Price
TROW
$24.3B
$1.4M 0.06%
13,940
NVDA icon
160
NVIDIA
NVDA
$5.27T
$1.39M 0.06%
309,480
+207,120
+202% +$804K
XPO icon
161
XPO
XPO
$23.5B
$1.38M 0.06%
74,164
-3,597
-5% -$69K
WSO icon
162
Watsco Inc
WSO
$13.5B
$1.37M 0.06%
9,560
+1,740
+22% +$250K
LLY icon
163
Eli Lilly
LLY
$1.1T
$1.36M 0.06%
10,465
THO icon
164
Thor Industries
THO
$4.14B
$1.35M 0.06%
21,660
+9,610
+80% +$609K
WHG icon
165
Westwood Holdings Group
WHG
$183M
$1.33M 0.05%
37,862
LSTR icon
166
Landstar System
LSTR
$6.05B
$1.32M 0.05%
12,050
+2,210
+22% +$233K
HRL icon
167
Hormel Foods
HRL
$13.6B
$1.31M 0.05%
29,375
REGN icon
168
Regeneron Pharmaceuticals
REGN
$83.2B
$1.31M 0.05%
3,200
GPC icon
169
Genuine Parts
GPC
$18.5B
$1.29M 0.05%
11,530
SBH icon
170
Sally Beauty Holdings
SBH
$1.57B
$1.27M 0.05%
69,210
+14,250
+26% +$255K
VFC icon
171
VF Corp
VFC
$5.86B
$1.25M 0.05%
15,240
-1,741
-10% -$136K
VB icon
172
Vanguard Morningstar Small-Cap ETF
VB
$82.5B
$1.25M 0.05%
8,152
+1,360
+20% +$202K
VNQ icon
173
Vanguard Real Estate ETF
VNQ
$38.6B
$1.24M 0.05%
14,248
+4,262
+43% +$352K
FFIN icon
174
First Financial Bankshares
FFIN
$4.93B
$1.21M 0.05%
41,760
+6,960
+20% +$213K
OMC icon
175
Omnicom Group
OMC
$23.2B
$1.19M 0.05%
16,359
+900
+6% +$67.6K

Similar funds

Bridges Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, Bridges Investment Management held 353 positions worth $2.45B, up 15% from $2.13B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bridges Investment Management's Q1 2019 filing shows 9 new, 138 increased, 125 reduced and 12 closed positions. Its largest new stake was Charles Schwab: 188,008 shares worth $8.04M. The largest sale was Eaton, an estimated $6.49M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Industrials.

  • Bridges Investment Management's largest Q1 2019 buy was Charles Schwab: 188,008 shares worth $8.04M.
  • Bridges Investment Management added most to Delta Air Lines in Q1 2019, an estimated $9.48M increase.
  • Bridges Investment Management's biggest Q1 2019 reduction was Eaton, cutting an estimated $6.49M.
  • Bridges Investment Management fully exited D.R. Horton in Q1 2019, selling an estimated $1.03M.
  • Bridges Investment Management's ten largest holdings make up 33% of its $2.45B portfolio in Q1 2019.
  • Bridges Investment Management opened 9 new positions and closed 12 in Q1 2019.
  • Bridges Investment Management's portfolio value rose 15% quarter-over-quarter to $2.45B.

Based on Bridges Investment Management's 13F filing for Q1 2019, filed 1 May 2019.